LSL Pharma Group Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2020
Period Ending	Feb '25 Feb 21, 2025	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Oct '20 Oct 3, 2020
Market Capitalization	41	40	-	-	-	-
Enterprise Value	55	54	-	-	-	-
Last Close Price	0.35	0.48	-	-	-	-
PS Ratio	2.18	3.99	-	-	-	-
PB Ratio	2.01	4.62	-	-	-	-
EV/Sales Ratio	3.47	5.37	-	-	-	-
Debt / Equity Ratio	0.69	1.88	2.84	1.15	1.02	1.41
Debt / EBITDA Ratio	21.54	-	-	47.86	4.08	12.69
Asset Turnover	0.47	0.34	0.29	0.31	-	-
Inventory Turnover	2.50	2.37	2.92	2.19	-	-
Quick Ratio	0.42	0.18	0.09	0.29	0.35	0.18
Current Ratio	1.17	0.48	0.38	0.89	0.52	0.33
Return on Equity (ROE)	-16.28%	-121.50%	-98.29%	-16.56%	-	-
Return on Assets (ROA)	-1.16%	-8.84%	-14.99%	-1.57%	-	-
Return on Capital (ROIC)	-1.35%	-11.37%	-19.12%	-1.98%	-	-
Return on Capital Employed (ROCE)	-	-	-	-	11.49%	3.84%
Earnings Yield	-5.98%	-21.19%	-	-	-	-
FCF Yield	-11.90%	-19.32%	-	-	-	-
Buyback Yield / Dilution	-24.72%	-20.88%	-11.78%	-8.34%	-14.88%	-
Total Shareholder Return	-24.72%	-20.88%	-11.78%	-8.34%	-14.88%	-

Source: S&P Capital IQ. Standard template. Financial Sources.